Trump health care plan likely good for pharmaceutical companies
Healthcare Under the Trump Administration: What to Expect Revamping Drug Pricing Strategies As the Trump administration takes office, pharmaceutical companies anticipate shifts in drug pricing policies. Unlike the hardline approach of the Biden administration, Trump may prioritize cost-cutting by targeting pharmacy benefit managers (PBMs) rather than directly implementing price controls on drugs. This change could … Read more
